$KRTL KRTL Holding Group Reports 2024 Financial Results and Advances Toward International Pharmaceutical Integration
otcmarkets.com/stock/KRTL/ne…
2024 Financial Highlights
• Net Income: Achieved net income of $887,587, compared to a net loss of $71,077 in 2023.
• Earnings Per Share (EPS): Reported EPS of $0.01 for 2024, versus $0.00 in the prior year.
• Non-Cash Revenue: Recognized non-cash revenue of $2.6 million for services provided in exchange for marketable securities.
• Investment Asset Growth: Increased investment asset value to $1.54 million at year-end 2024, up from $380,000 in 2023.
• Capital Structure: Maintained a streamlined capital structure with 87.2 million shares of common stock issued and outstanding.
This financial turnaround reflects early gains from cross-border licensing strategy, regulatory platform scalability, and international manufacturing synergies.